Health Care/Hospital

Momcozy Celebrates Motherhood with "Momcozy Village" Event at Babylist Beverly Hills

NEW YORK, May 10, 2024 /PRNewswire/ -- On May 9th, Momcozy , a global leader in mother and baby care, hosted a heartwarming event at Babylist Beverly Hills as part of its "Momcozy Village

2024-05-10 22:00 556

China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering

HANGZHOU, China, May 10, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ha...

2024-05-10 21:20 804

Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)

SHENZHEN, China, May 10, 2024 /PRNewswire/ -- On the evening of May 5, Kexing Biopharm (stock code: 688136) announced it had obtained a "Certificate of GMP Compliance of a Manufacturer" granted by the Norwegian Medical Products Agency in accordance with the European Medicines Agency (EMA) regulat...

2024-05-10 20:07 802

Nuvilab Becomes B Corp Certified

SEOUL, South Korea, May 10, 2024 /PRNewswire/ -- Nuvilab, a leading provider of food vision AI, announced its recent achievement of becoming a certified B Corp. The designation, granted by the non-profit B Lab, highlights Nuvilab's commitment to a range of sustainable practices encompassing gover...

2024-05-10 19:59 825

Ribobay Pharma boosts CRDMO offerings with Cytiva's first FlexFactory platform for oligonucleotides

* FlexFactory platform for oligonucleotides, an integrated solution to boost efficiency and speed of pharmaceutical manufacturing to meet market demand SHANGHAI, May 10, 2024 /PRNewswire/ -- Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing o...

2024-05-10 18:39 909

RemeGen Celebrates World Lupus Day 2024 with Increased Lupus Visibility through Vital Knowledge Sharing

The biotech company continues to offer hope to systemic lupus erythematosus ( SLE) patients globally by sharing the latest developments of its proprietary novel fusion protein drug Telitacicept YANTAI, China, May 10, 2024 /PRNewswire/ -- RemeGen Co. Ltd.  ("RemeGen" or "t...

2024-05-10 16:26 1023

WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval

CHENGDU, China, May 10, 2024 /PRNewswire/ -- WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA ...

2024-05-10 12:16 1210

SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer

SEOUL, South Korea, May 9, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101 ...

2024-05-10 12:00 847

Diagnostic Imaging for Women Enhances Mammography Quality with AI: Results Presented at ASMIRT 2024

DARWIN, Australia, May 10, 2024 /PRNewswire/ -- At the Australian Society of Medical Imaging and Radiation Therapy (ASMIRT) conference this week in Darwin, Diagnostic Imaging for Women (difw), together with Volpara Health announced significant advancements in applying AI to mammography quality as...

2024-05-10 08:58 895

Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition cost

* Adalimumab-aaty will be priced at an 85% discount to HUMIRA® (adalimumab) * Branded and unbranded versions of Celltrion USA's adalimumab biosimilar help provide more affordable options for patients JERSEY CITY, N.J., May 9, 2024 /PRNewswire/ -- CelltrionUSA announced today that adalimumab-aa...

2024-05-10 07:41 666

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

First and only contact force pulsed field ablation (PFA) system designed to transform treatment for millions with life-threatening ventricular arrhythmias. Preliminary data of VCAS study will be presented at HRS 2024 in Boston, Mass. CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field M...

2024-05-09 20:03 1093

FDA Clears the Individualized Nomogram for Rika Plasma Donation System

The latest innovation is anticipated to increase collection volume without increasing collection time * Rika's individualized nomogram, iNomi, can enable plasma donors to donate the right amount of plasma on any given day based on height, weight and hematocrit. * The Rika Plasma Donation Sys...

2024-05-09 20:00 690

Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines

Publication in Human Vaccines and Immunotherapeutics highlights progress in understanding tumour biology and vaccine technologies since the pandemic OXFORD, England, May 9, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in pr...

2024-05-09 15:30 954

Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines

Publication in Human Vaccines and Immunotherapeutics highlights progress in understanding tumour biology and vaccine technologies since the pandemic OXFORD, England, May 9, 2024 /PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in pr...

2024-05-09 15:30 951

Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

TAIPEI, May 9, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing Company ("Tabuk"), for exclusive rights to the commercialization of clobetasol...

2024-05-09 15:00 1197

Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions

TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximatelyJPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The GHIT Fund inv...

2024-05-09 10:00 1007

Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints

SAN FRANCISCO and SUZHOU, China, May 9, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, o...

2024-05-09 08:00 1195

TraceLink Named to 2024 RXinsider Pharmacy500 List

BOSTON, May 9, 2024 /PRNewswire/ -- TraceLink, a leader in end-to-end digital supply chain solutions, is proud to announce its inclusion in the Pharmacy500 list for 2024 by RXinsider. This recognition places TraceLink among the most impactful pharmacy supply chain companies inthe United States, a...

2024-05-09 00:53 776

Registration opens for Medtec China 2024

BEIJING, May 9, 2024 /PRNewswire/ -- According to the report of China Federation of Logistics & Purchasing (CFLP), the market size of China's medical device sector reachedRMB 1,250 billion in 2023, with a growth rate 2.4 times faster than that of the global medical device industry. To Vigorously ...

2024-05-09 00:00 695

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias

AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024. This year's event included 1,000 registered attendees from all over the glob...

2024-05-08 23:25 589
12345 ... 809

Week's Top Stories